Login to Your Account



Bone Therapeutics Gets $10M for Cell Therapy Development

By Cormac Sheridan
Staff Writer

Wednesday, January 30, 2013
Bone Therapeutics SA raised €7.7 million (US$10.4 million) in new financing as a prelude to a larger round, as it seeks to expand the indication range for its cell therapy product Preob.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription